January 22, 2020 - The FDA states that those who experience shortness of breath, chest pain, have trouble talking, become dizzy, experience a sudden, severe headache, experience numbness or weakness on one side of the body or develop an irregular or rapid heartbeat while taking Uloric should immediately seek medical attention...

December 23, 2019 - FDA Black Box Uloric Warning - In February 2019, the FDA issued a Black Box Warning regarding Uloric which noted a clinical trial concluded that Uloric might not just be responsible for an increase in cardiovascular deaths—but in deaths from all causes. Uloric is manufactured by Takeda for a type of arthritis known as gout which occurs when uric acid...